Wrist monitor study for itch in eczema and psoriasis
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study tests whether a wrist-worn device can accurately measure scratching during sleep in people with eczema (atopic dermatitis) or psoriasis. It may help doctors better understand and treat nighttime itching.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have eczema (atopic dermatitis) and are between 14 and 69 years old, or you have psoriasis and are between 18 and 69 years old.
- Your itching from eczema or psoriasis is moderate to severe (a score above 1 for eczema, or above 4 for psoriasis).
- You do not have a diagnosed sleep disorder (like sleep apnea or restless leg syndrome) or a movement disorder.
- You are not pregnant or breastfeeding, and you do not work night shifts or have jet lag.
- You do not have a current diagnosis of depression, an infection on your wrist, or infected skin lesions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether meditation can reduce itching and improve quality of life in adults with plaque psoriasis or atopic dermatitis (eczema). It may help by calming the mind and reducing discomfort related to inflammatory skin disease.
This study tests whether roflumilast cream (a new anti-inflammatory medication applied to the skin) can reduce the intense itching caused by atopic dermatitis (eczema). You'll track your itching daily using a smartphone app and visit the clinic to see if the cream helps over time.
This trial tests a mobile app designed to help reduce itching and related symptoms for people with psoriasis, eczema, or chronic hives. If you have moderate to severe itch and can use an English-language app, this study might be for you.
This trial tests whether a cosmetic cream can reduce eczema flare-ups and is comfortable/safe to use on very dry, irritated, eczema-prone skin. It’s mainly for children who have had recent flare-ups and moderate eczema severity.
This trial studies whether dupilumab can improve daily body clock (circadian function), sleep, and itching in children with moderate-to-severe eczema that isn’t well controlled by creams. It may help kids who are having significant sleep trouble and ongoing itch.
This study tests a non-invasive home device called Nevisense Go that may help detect atopic dermatitis (eczema) flares before they become severe. You'll use the device at home, track your symptoms, and visit the clinic a few times to see if it helps predict when flares are coming.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.